Literature DB >> 632994

Medical management of small preterm infants with symptomatic patent ductus arteriosus.

R B Cotton, M T Stahlman, I Kovar, W Z Catterton.   

Abstract

During 1975, 38 of 44 infants with a birth weight of less than or equal to 1,500 gm who developed pulmonary edema and congestive heart failure due to a patent ductus arteriosus were managed medically until the ductus closed spontaneously days or weeks later. Overall survival was 71%, and there were no deaths among 11 infants weighing more than 1,250 gm. Pulmonary complications were prevalent and were attributed to the extensive use of mechanical ventilation required to control pulmonary edema. The results of this study document the results to be expected when small preterm infants with a symptomatic patent ductus arteriosus are managed without surgical or pharmacologic intervention and provide a basis for the rational design of clinical trials evaluating other management approaches.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 632994     DOI: 10.1016/s0022-3476(78)80451-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  39 in total

1.  Clinical profile and management of PDA in neonates.

Authors:  C C Shanthala; P P Maiya; D Vishwanath; N Banakappa; P M Swamy; N Desai; K H Srinivas
Journal:  Indian J Pediatr       Date:  1997 Sep-Oct       Impact factor: 1.967

2.  Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.

Authors:  Arne Ohlsson; Sachin S Shah
Journal:  Cochrane Database Syst Rev       Date:  2019-06-21

Review 3.  Unexpected extra-renal effects of loop diuretics in the preterm neonate.

Authors:  Robert Cotton; Sandra Suarez; Jeff Reese
Journal:  Acta Paediatr       Date:  2012-05-28       Impact factor: 2.299

4.  Regulation of the fetal mouse ductus arteriosus is dependent on interaction of nitric oxide and COX enzymes in the ductal wall.

Authors:  Jeff Reese; Patrick W O'Mara; Stanley D Poole; Naoko Brown; Chelsea Tolentino; Delrae M Eckman; Judy L Aschner
Journal:  Prostaglandins Other Lipid Mediat       Date:  2008-11-13       Impact factor: 3.072

5.  Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.

Authors:  Arne Ohlsson; Sachin S Shah
Journal:  Cochrane Database Syst Rev       Date:  2020-01-27

6.  Treatment and Nontreatment of the Patent Ductus Arteriosus: Identifying Their Roles in Neonatal Morbidity.

Authors:  Ronald I Clyman; Melissa Liebowitz
Journal:  J Pediatr       Date:  2017-07-11       Impact factor: 4.406

Review 7.  Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.

Authors:  Manoj N Malviya; Arne Ohlsson; Sachin S Shah
Journal:  Cochrane Database Syst Rev       Date:  2013-03-28

8.  Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome.

Authors:  Juliette C Madan; Douglas Kendrick; James I Hagadorn; Ivan D Frantz
Journal:  Pediatrics       Date:  2009-02       Impact factor: 7.124

9.  Cimetidine-associated patent ductus arteriosus is mediated via a cytochrome P450 mechanism independent of H2 receptor antagonism.

Authors:  Robert B Cotton; Lisa P Shah; Stanley D Poole; Noah J Ehinger; Naoko Brown; Elaine L Shelton; James C Slaughter; H Scott Baldwin; Bibhash C Paria; Jeff Reese
Journal:  J Mol Cell Cardiol       Date:  2013-02-27       Impact factor: 5.000

10.  Surgical treatment of patent ductus arteriosus in preterm infants. Four-year experience with ligation in the newborn intensive care unit.

Authors:  L D Eggert; A J Jung; E C MCGough; H D Ruttenberg
Journal:  Pediatr Cardiol       Date:  1982       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.